155 related articles for article (PubMed ID: 26809303)
1. [Gemcitabine Monotherapy for Advanced Mycosis Fungoides--Two Case Reports and a Literature Review].
Masuzawa M; Takasu H; Amoh Y
Gan To Kagaku Ryoho; 2015 Dec; 42(13):2451-5. PubMed ID: 26809303
[TBL] [Abstract][Full Text] [Related]
2. Treatment of transformed mycosis fungoides with intermittent low-dose gemcitabine.
Awar O; Duvic M
Oncology; 2007; 73(1-2):130-5. PubMed ID: 18337626
[TBL] [Abstract][Full Text] [Related]
3. Phase II evaluation of gemcitabine monotherapy for cutaneous T-cell lymphoma.
Duvic M; Talpur R; Wen S; Kurzrock R; David CL; Apisarnthanarax N
Clin Lymphoma Myeloma; 2006 Jul; 7(1):51-8. PubMed ID: 16879770
[TBL] [Abstract][Full Text] [Related]
4. Gemcitabine treatment in cutaneous T-cell lymphoma: a multicentre study of 23 cases.
Jidar K; Ingen-Housz-Oro S; Beylot-Barry M; Paul C; Chaoui D; Sigal-Grinberg M; Morel P; Dubertret L; Bachelez H
Br J Dermatol; 2009 Sep; 161(3):660-3. PubMed ID: 19438862
[TBL] [Abstract][Full Text] [Related]
5. Low-dose gemcitabine efficacious in three patients with tumor-stage mycosis fungoides.
Buhl T; Bertsch HP; Kaune KM; Mitteldorf C; Schön MP; Kretschmer L
Clin Lymphoma Myeloma; 2009 Oct; 9(5):E21-4. PubMed ID: 19858049
[TBL] [Abstract][Full Text] [Related]
6. Gemcitabine treatment in pretreated cutaneous T-cell lymphoma: experience in 44 patients.
Zinzani PL; Baliva G; Magagnoli M; Bendandi M; Modugno G; Gherlinzoni F; Orcioni GF; Ascani S; Simoni R; Pileri SA; Tura S
J Clin Oncol; 2000 Jul; 18(13):2603-6. PubMed ID: 10893292
[TBL] [Abstract][Full Text] [Related]
7. Combination of etoposide, idarubicin, cyclophosphamide, vincristine, prednisone and bleomycin (VICOP-B) in the treatment of advanced cutaneous T-cell lymphoma.
Fierro MT; Doveil GC; Quaglino P; Savoia P; Verrone A; Bernengo MG
Dermatology; 1997; 194(3):268-72. PubMed ID: 9187846
[TBL] [Abstract][Full Text] [Related]
8. Familial cutaneous mycosis fungoides: successful treatment with a combination of gemcitabine and alemtuzumab.
Weder P; Anliker M; Itin P; Bargetzi M
Dermatology; 2004; 208(3):281-3. PubMed ID: 15118391
[TBL] [Abstract][Full Text] [Related]
9. Systemic chemotherapy promotes HIF-1α-mediated glycolysis and IL-17F pathways in cutaneous T-cell lymphoma.
Wang B; Li K; Wang H; Shen X; Zheng J
Exp Dermatol; 2020 Oct; 29(10):987-992. PubMed ID: 32573814
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of patients with advanced-stage cutaneous T cell lymphoma treated with gemcitabine.
Pellegrini C; Stefoni V; Casadei B; Maglie R; Argnani L; Zinzani PL
Ann Hematol; 2014 Nov; 93(11):1853-7. PubMed ID: 24908331
[TBL] [Abstract][Full Text] [Related]
11. Clinical Outcomes of Advanced-Stage Cutaneous Lymphoma under Low-Dose Gemcitabine Treatment: Real-Life Data from the German Cutaneous Lymphoma Network.
Blazejak C; Stranzenbach R; Gosman J; Gambichler T; Wehkamp U; Stendel S; Klemke CD; Wobser M; Olk J; Nicolay JP; Weyermann M; Stadler R; Assaf C
Dermatology; 2022; 238(3):498-506. PubMed ID: 34474414
[TBL] [Abstract][Full Text] [Related]
12. Safety and effectiveness of the combination of systemic gemcitabine and intralesional brentuximab vedotin in tumor-stage mycosis fungoides.
Torre-Castro J; Recio-Monescillo M; Castillo Bazan E; Díaz de la Pinta J; Rodríguez Pinilla M; Requena L; Córdoba R
Int J Dermatol; 2024 Jun; 63(6):828-830. PubMed ID: 38419393
[No Abstract] [Full Text] [Related]
13. Gemcitabine as frontline treatment for cutaneous T-cell lymphoma: phase II study of 32 patients.
Marchi E; Alinari L; Tani M; Stefoni V; Pimpinelli N; Berti E; Pagano L; Bernengo MG; Zaja F; Rupoli S; Pileri S; Baccarani M; Zinzani PL
Cancer; 2005 Dec; 104(11):2437-41. PubMed ID: 16216001
[TBL] [Abstract][Full Text] [Related]
14. Gemcitabine and vinorelbine treatment in cutaneous T-cell lymphoma in four patients.
Affandi AM; Blumetti TP; Wells J; Hertzberg M; Fernandez-Peñas P
Australas J Dermatol; 2015 Nov; 56(4):294-7. PubMed ID: 25496219
[TBL] [Abstract][Full Text] [Related]
15. Therapy with gemcitabine in pretreated peripheral T-cell lymphoma patients.
Zinzani PL; Magagnoli M; Bendandi M; Orcioni GF; Gherlinzoni F; Albertini P; Pileri SA; Tura S
Ann Oncol; 1998 Dec; 9(12):1351-3. PubMed ID: 9932168
[TBL] [Abstract][Full Text] [Related]
16. Widespread Skin Necrosis Secondary to Gemcitabine Therapy.
Zito PM; Gonzalez AM; Fox JD; Cronin M; Mackrides N; Kirsner RS; Nichols AJ
J Drugs Dermatol; 2018 May; 17(5):582-585. PubMed ID: 29742194
[TBL] [Abstract][Full Text] [Related]
17. Granulomatous mycosis fungoides responsive to gemcitabine.
Fargnoli MC; Peris K; Francesconi F; Cantonetti M; Cerroni L; Chimenti S
Eur J Dermatol; 2002; 12(5):479-81. PubMed ID: 12370140
[TBL] [Abstract][Full Text] [Related]
18. Granulomatous mycosis fungoides with large cell transformation misdiagnosed as leprosy.
Siriphukpong S; Pattanaprichakul P; Sitthinamsuwan P; Karoopongse E
J Med Assoc Thai; 2010 Nov; 93(11):1321-6. PubMed ID: 21114213
[TBL] [Abstract][Full Text] [Related]
19. A case of advanced mycosis fungoides with comprehensive skin and visceral organs metastasis: sensitive to chemical and biological therapy.
Liu YQ; Zhu WY; Shu YQ; Gu YH
Asian Pac J Trop Med; 2012 Aug; 5(8):669-72. PubMed ID: 22840460
[TBL] [Abstract][Full Text] [Related]
20. Treatment with alemtuzumab in a case of refractory primary cutaneous CD30-negative CD8-positive cytotoxic large T-cell lymphoma.
Gutierrez A; Rodriguez J; Ramos R; Gines J; Sampol A; Galmes B; Besalduch J
Eur J Haematol; 2004 May; 72(5):377-8. PubMed ID: 15059077
[No Abstract] [Full Text] [Related]
[Next] [New Search]
